SCHEMBL14219224

SCHEMBL14219224

CCCCNC(=O)CNC(=O)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.61
TSHR P16473 1/20 0.56
HTT P42858 1/20 0.56
HDAC3 O15379 4/20 0.55
HDAC1 Q13547 4/20 0.55
HDAC2 Q92769 4/20 0.55
MEN1 O00255 1/20 0.55
GAA P10253 1/20 0.55
KMT2A Q03164 1/20 0.55
GPR139 Q6DWJ6 1/20 0.54
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
HDAC4 P56524 3/20 0.51
HDAC7 Q8WUI4 3/20 0.51
HDAC10 Q969S8 3/20 0.51
HDAC11 Q96DB2 3/20 0.51
HDAC8 Q9BY41 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
HDAC9 Q9UKV0 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11850039 0.94 NAAA (0.79) NAAASMN1; SMN2HTTHDAC3HDAC1
SCHEMBL11854495 0.94 NAAA (0.79) NAAASMN1; SMN2HTTHDAC3HDAC1
SCHEMBL11854068 0.94 NAAA (0.79) NAAASMN1; SMN2HTTHDAC3HDAC1
SCHEMBL11853375 0.94 NAAA (0.79) NAAASMN1; SMN2HTTHDAC3HDAC1
SCHEMBL11841161 0.94 NAAA (0.79) NAAASMN1; SMN2HTTHDAC3HDAC1
SCHEMBL11852545 0.94 NAAA (0.79) NAAASMN1; SMN2HTTHDAC3HDAC1
SCHEMBL11854927 0.94 NAAA (0.79) NAAASMN1; SMN2HTTHDAC3HDAC1
SCHEMBL9545406 0.90 NAAA (0.58) NAAASMN1; SMN2TSHRHDAC3HDAC1
SCHEMBL1002854 0.88 NAAA (0.86) NAAASMN1; SMN2TSHRHTTHDAC3
Bromide SCHEMBL4760760 0.86 NAAA (0.83) NAAASMN1; SMN2TSHRHTTHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1911438-A2 Cosmetic composition containing a derivative of dibenzoylmethane and a arylalkyl amide or ester compound; method of photostabilising the derivative of dibenzoylmethane L'Oréal (FR) 2008-04-16 EP disclosed
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds L'OREAL (FR) 2008-01-24 US disclosed
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds L'OREAL (FR) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080019930-A1 Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds TYR, DDT, AADAC NAAA 332/4885SMN1; SMN2 4459/4885TSHR 4288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.